Irisin level in response to the patients with metabolic impairments

Basit Öğe Kaydı
dc.contributor.authorAlgul, S.
dc.contributor.authorOzcan, S.
dc.contributor.authorBarutcu, A.
dc.contributor.authorSerhatlioglu, I.
dc.contributor.authorBerilgen, S.
dc.contributor.authorOzcelik, O.
dc.date.accessioned2026-08-12T18:13:16Z
dc.date.issued2014
dc.departmentFırat Üniversitesi
dc.description.abstract[Abstract Not Available]
dc.identifier.endpage137
dc.identifier.issn1748-1708
dc.identifier.issn1748-1716
dc.identifier.startpage137
dc.identifier.urihttps://hdl.handle.net/11508/64318
dc.identifier.volume211
dc.identifier.wosWOS:000340586900343
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.language.isoen
dc.publisherWiley-Blackwell
dc.relation.ispartofActa Physiologica
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WoS_20260511
dc.subjectIrisin
dc.subjectcerebrovascular disorders
dc.subjectmyocardial infarction
dc.subjectpulmonary disease
dc.titleIrisin level in response to the patients with metabolic impairments
dc.typeConference Object

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu